about
Identification of HDAC6-Selective Inhibitors of Low Cancer Cell CytotoxicityThe amino terminus of tau inhibits kinesin-dependent axonal transport: implications for filament toxicity.Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models.Use of molecular modeling, docking, and 3D-QSAR studies for the determination of the binding mode of benzofuran-3-yl-(indol-3-yl)maleimides as GSK-3beta inhibitorsGlycogen synthase kinase-3β is a functional modulator of serotonin-1B receptorsGlycogen synthase kinase 3β inhibitors induce apoptosis in ovarian cancer cells and inhibit in-vivo tumor growthIdentification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, that Prolongs the Median Survival Time of Δ7 SMA KO Mouse Model of Spinal Muscular Atrophy.Structure-guided design of a highly selective glycogen synthase kinase-3β inhibitor: a superior neuroprotective pyrazolone showing antimania effectsDistinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease.Bioactive Flavonoids and Catechols as Hif1 and Nrf2 Protein Stabilizers - Implications for Parkinson's Disease.Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer.Catalytic mechanism and substrate specificity of HIF prolyl hydroxylases.GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression.Highly potent and specific GSK-3beta inhibitors that block tau phosphorylation and decrease alpha-synuclein protein expression in a cellular model of Parkinson's disease.ATPS-91GSK-3 INHIBITOR 9-ING-41 ENHANCES GENOTOXIC THERAPY OF GBM LEADING TO CURE FROM INTRACRANIAL BRAIN TUMOR.Activation of Nrf2 and Hypoxic Adaptive Response Contribute to Neuroprotection Elicited by Phenylhydroxamic Acid Selective HDAC6 Inhibitors.Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.L-ascorbic acid: a true substrate for HIF proly hydroxylase?Structure-activity relationship for branched oxyquinoline HIF activators: Effect of modifications to phenylacetamide "tail".Optimization of 4-Aminopiperidines as Inhibitors of Influenza A Viral Entry That Are Synergistic with OseltamivirDiscovery of suppressors of CRMP2 phosphorylation reveals compounds that mimic the behavioral effects of lithium on amphetamine-induced hyperlocomotion
P50
Q30366109-63B9848D-1846-4ADA-AF6C-54910AAAD415Q30490027-961A57CD-E586-4C78-BA6F-04280933B1C5Q33869702-8664E980-02FC-45B5-96BA-8DF579CB009DQ34202269-BBDA2DEB-587A-48EA-948A-A438C91CC4B2Q35008919-7A5CECF5-E1DB-494B-9C44-26F1BB3E39CAQ35281886-29CD2E18-3EEB-4FAA-8579-534A389602FEQ35758331-529CA50C-52B1-4746-8EC8-D8CDAE8E8B6EQ36191316-4B58483B-862D-4A1D-8197-5808430C8F44Q36985371-958CD48D-D2DF-4245-8277-23CE948706AEQ37545889-B5072308-7C7C-41F1-AD40-CBF3C14595CFQ37640802-EDDB7A02-208D-4D04-B746-AF70B1ADD750Q38060193-F2329D7C-C32E-4913-89A9-23C02E8CB49EQ38798496-1FCB37F8-9F71-46FB-8A94-5F192E2D1768Q40246572-5A6E776D-6014-4576-BB74-01A7A1D643F4Q45830769-5F2E1573-B9AD-46CA-8FD1-8EDF0805E800Q47862291-19E5671D-3494-4EBA-968B-AB6A0DB1DD57Q48023073-5BC5F727-273C-47F4-A13D-6D72CD8FC3D6Q49385368-8AD710C3-0CD9-43C7-8DEB-5D954F834373Q51068738-54A6D8BB-C9C0-4818-83F6-D0E3494102B9Q89758270-C7E2F3B9-A6B3-49BB-BD31-E1520D9F6834Q89865705-DEEE4F2A-F030-4B4E-9055-500A13C52397
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Irina Gaisina
@en
Irina N Gaisina
@ast
Irina N Gaisina
@es
Irina N Gaisina
@nl
Irina Nikolajewna Gaissina
@de
Ирина Николаевна Гайсина
@ru
type
label
Irina Gaisina
@en
Irina N Gaisina
@ast
Irina N Gaisina
@es
Irina N Gaisina
@nl
Irina Nikolajewna Gaissina
@de
Ирина Николаевна Гайсина
@ru
altLabel
Irina Gaissina
@de
Irina Gaysina
@en
Irina N Gaisina
@en
Irina Nikolayevna Gaysina
@en
prefLabel
Irina Gaisina
@en
Irina N Gaisina
@ast
Irina N Gaisina
@es
Irina N Gaisina
@nl
Irina Nikolajewna Gaissina
@de
Ирина Николаевна Гайсина
@ru
P106
P21
P31
P496
0000-0002-8668-3222